{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T12:56:45Z","timestamp":1778504205114,"version":"3.51.4"},"reference-count":85,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Clinics of North America"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.suc.2020.02.003","type":"journal-article","created":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T01:01:11Z","timestamp":1586566871000},"page":"507-521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Esophagus and Gastrointestinal Junction Tumors"],"prefix":"10.1016","volume":"100","author":[{"given":"Saba","family":"Kurtom","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian J.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.suc.2020.02.003_bib1","series-title":"SEER Cancer Statistics Review, 1975\u20132016","year":"2019"},{"key":"10.1016\/j.suc.2020.02.003_bib2","series-title":"Global Cancer Facts & Figures 4th Edition","year":"2018"},{"key":"10.1016\/j.suc.2020.02.003_bib3","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.canep.2016.01.013","article-title":"The epidemic of oesophageal carcinoma: where are we now?","volume":"41","author":"Thrift","year":"2016","journal-title":"Cancer Epidemiol"},{"issue":"2","key":"10.1016\/j.suc.2020.02.003_bib4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/(SICI)1097-0215(19981005)78:2<149::AID-IJC4>3.0.CO;2-Z","article-title":"Proliferative activity of cancer cells in front and center areas of carcinoma in\u00a0situ and invasive sites of esophageal squamous-cell carcinoma","volume":"78","author":"Kuwano","year":"1998","journal-title":"Int J Cancer"},{"issue":"17","key":"10.1016\/j.suc.2020.02.003_bib5","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1093\/jnci\/88.17.1222","article-title":"Immunocytochemical detection of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma","volume":"88","author":"Thorban","year":"1996","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"26","key":"10.1016\/j.suc.2020.02.003_bib6","doi-asserted-by":"crossref","first-page":"7933","DOI":"10.3748\/wjg.v21.i26.7933","article-title":"Esophageal cancer: risk factors, screening and endoscopic treatment in Western and Eastern countries","volume":"21","author":"Domper Arnal","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.suc.2020.02.003_bib7","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.suc.2012.07.008","article-title":"Epidemiology of esophageal cancer","volume":"92","author":"Wheeler","year":"2012","journal-title":"Surg Clin North Am"},{"issue":"3","key":"10.1016\/j.suc.2020.02.003_bib8","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/ajg.2010.415","article-title":"Meat consumption and risk of esophageal and gastric cancer in a large prospective study","volume":"106","author":"Cross","year":"2011","journal-title":"Am J Gastroenterol"},{"issue":"21","key":"10.1016\/j.suc.2020.02.003_bib9","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1093\/jnci\/92.21.1753","article-title":"Prospective study of serum selenium levels and incident esophageal and gastric cancers","volume":"92","author":"Mark","year":"2000","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.suc.2020.02.003_bib10","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/jnci\/dji042","article-title":"Zinc concentration in esophageal biopsy specimens measured by x-ray fluorescence and esophageal cancer risk","volume":"97","author":"Abnet","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"14","key":"10.1016\/j.suc.2020.02.003_bib11","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/jnci\/90.14.1039","article-title":"The concise handbook of family cancer syndromes. Mayo Familial Cancer Program","volume":"90","author":"Lindor","year":"1998","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"38","key":"10.1016\/j.suc.2020.02.003_bib12","first-page":"1","article-title":"Concise handbook of familial cancer susceptibility syndromes - second edition","author":"Lindor","year":"2008","journal-title":"J\u00a0Natl Cancer Inst Monogr"},{"key":"10.1016\/j.suc.2020.02.003_bib13","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1093\/hmg\/5.Supplement_1.1457","article-title":"Molecular genetics of Bloom's syndrome","volume":"5 Spec No","author":"Ellis","year":"1996","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.1016\/j.suc.2020.02.003_bib14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.5732\/cjc.011.10390","article-title":"Epidemiologic differences in esophageal cancer between Asian and Western populations","volume":"31","author":"Zhang","year":"2012","journal-title":"Chin J Cancer"},{"issue":"3","key":"10.1016\/j.suc.2020.02.003_bib15","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.cgh.2015.10.005","article-title":"The Male Predominance in Esophageal Adenocarcinoma","volume":"14","author":"Xie","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.suc.2020.02.003_bib16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00000478-199502000-00007","article-title":"Surgical pathology of adenocarcinoma arising in Barrett's esophagus. Analysis of 67 cases","volume":"19","author":"Paraf","year":"1995","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.suc.2020.02.003_bib17","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0022-5223(95)70428-0","article-title":"Carcinoma of the esophagus. Prognostic significance of histologic type","volume":"109","author":"Lieberman","year":"1995","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"10","key":"10.1016\/j.suc.2020.02.003_bib18","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1111\/j.1365-2036.2010.04471.x","article-title":"Meta-analysis: the association of oesophageal adenocarcinoma with symptoms of gastro-oesophageal reflux","volume":"32","author":"Rubenstein","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.suc.2020.02.003_bib19","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/j.1572-0241.1998.00362.x","article-title":"Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology","volume":"93","author":"Sampliner","year":"1998","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.suc.2020.02.003_bib20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bpg.2014.11.004","article-title":"Barrett's oesophagus diagnostic criteria: endoscopy and histology","volume":"29","author":"Naini","year":"2015","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"15","key":"10.1016\/j.suc.2020.02.003_bib21","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1056\/NEJMoa1103042","article-title":"Incidence of adenocarcinoma among patients with Barrett's esophagus","volume":"365","author":"Hvid-Jensen","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.suc.2020.02.003_bib22","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.gie.2007.07.019","article-title":"Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis","volume":"67","author":"Rastogi","year":"2008","journal-title":"Gastrointest Endosc"},{"issue":"9","key":"10.1016\/j.suc.2020.02.003_bib23","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJMra1314704","article-title":"Barrett's esophagus","volume":"371","author":"Spechler","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.suc.2020.02.003_bib24","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/ajg.2010.171","article-title":"Low-grade dysplasia in Barrett's esophagus: overdiagnosed and underestimated","volume":"105","author":"Curvers","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.suc.2020.02.003_bib25","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1053\/j.gastro.2011.06.055","article-title":"Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagus","volume":"141","author":"Wani","year":"2011","journal-title":"Gastroenterology"},{"issue":"17","key":"10.1016\/j.suc.2020.02.003_bib26","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/jnci\/djq289","article-title":"Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium","volume":"102","author":"Cook","year":"2010","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.suc.2020.02.003_bib27","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/annonc\/mdr136","article-title":"A\u00a0meta-analysis on alcohol drinking and esophageal and gastric cardia adenocarcinoma risk","volume":"23","author":"Tramacere","year":"2012","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.suc.2020.02.003_bib28","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/annonc\/mds244","article-title":"A\u00a0meta-analysis of body mass index and esophageal and gastric cardia adenocarcinoma","volume":"24","author":"Turati","year":"2013","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.suc.2020.02.003_bib29","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1053\/j.gastro.2011.11.019","article-title":"Nonsteroidal anti-inflammatory drug use reduces risk of adenocarcinomas of the esophagus and esophagogastric junction in a pooled analysis","volume":"142","author":"Liao","year":"2012","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.suc.2020.02.003_bib30","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1158\/1078-0432.CCR-07-4932","article-title":"A\u00a0functional epidermal growth factor (EGF) polymorphism, EGF serum levels, and esophageal adenocarcinoma risk and outcome","volume":"14","author":"Lanuti","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.suc.2020.02.003_bib31","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1158\/1055-9965.EPI-09-1136","article-title":"A\u00a0segregation analysis of Barrett's esophagus and associated adenocarcinomas","volume":"19","author":"Sun","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"10.1016\/j.suc.2020.02.003_bib32","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/jnci\/djh057","article-title":"Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia","volume":"96","author":"Ye","year":"2004","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.suc.2020.02.003_bib33","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1572-0241.1998.00394.x","article-title":"Helicobacter pylori infection, reflux esophagitis, and atrophic gastritis: an unexplored triangle","volume":"93","author":"Xia","year":"1998","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.suc.2020.02.003_bib34","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s10620-016-4368-y","article-title":"Gastrointestinal bleeding due to gastrointestinal tract malignancy: natural history, management, and outcomes","volume":"62","author":"Schatz","year":"2017","journal-title":"Dig Dis Sci"},{"issue":"11","key":"10.1016\/j.suc.2020.02.003_bib35","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1097\/00003072-200011000-00005","article-title":"Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography","volume":"25","author":"Meltzer","year":"2000","journal-title":"Clin Nucl Med"},{"issue":"2","key":"10.1016\/j.suc.2020.02.003_bib36","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.radonc.2015.07.011","article-title":"Clinical efficacy and failure pattern in patients with cervical esophageal cancer treated with definitive chemoradiotherapy","volume":"116","author":"Zhang","year":"2015","journal-title":"Radiother Oncol"},{"issue":"8","key":"10.1016\/j.suc.2020.02.003_bib37","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/ajg.2014.156","article-title":"Surveillance of Barrett's esophagus and mortality from esophageal adenocarcinoma: a population-based cohort study","volume":"109","author":"Verbeek","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.suc.2020.02.003_bib38","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1053\/j.gastro.2015.04.053","article-title":"Epidemiology, diagnosis, and management of esophageal adenocarcinoma","volume":"149","author":"Rubenstein","year":"2015","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.suc.2020.02.003_bib39","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/ajg.2015.322","article-title":"ACG clinical guideline: diagnosis and management of Barrett's esophagus","volume":"111","author":"Shaheen","year":"2016","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.suc.2020.02.003_bib40","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.gie.2011.09.016","article-title":"Diagnostic accuracy of EUS in differentiating mucosal versus submucosal invasion of superficial esophageal cancers: a systematic review and meta-analysis","volume":"75","author":"Thosani","year":"2012","journal-title":"Gastrointest Endosc"},{"issue":"4","key":"10.1016\/j.suc.2020.02.003_bib41","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.gie.2010.10.046","article-title":"Do we still need EUS in the workup of patients with early esophageal neoplasia? A retrospective analysis of 131 cases","volume":"73","author":"Pouw","year":"2011","journal-title":"Gastrointest Endosc"},{"issue":"4","key":"10.1016\/j.suc.2020.02.003_bib42","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0016-5107(94)70206-3","article-title":"Endosonographic features predictive of lymph node metastasis","volume":"40","author":"Catalano","year":"1994","journal-title":"Gastrointest Endosc"},{"issue":"6","key":"10.1016\/j.suc.2020.02.003_bib43","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1067\/mge.2002.122650","article-title":"Helical CT versus EUS with fine needle aspiration for celiac nodal assessment in patients with esophageal cancer","volume":"55","author":"Romagnuolo","year":"2002","journal-title":"Gastrointest Endosc"},{"issue":"1","key":"10.1016\/j.suc.2020.02.003_bib44","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.gassur.2004.09.055","article-title":"Positron emission tomography with F-18-fluorodeoxyglucose in a combined staging strategy of esophageal cancer prevents unnecessary surgical explorations","volume":"9","author":"van Westreenen","year":"2005","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"3","key":"10.1016\/j.suc.2020.02.003_bib45","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/S0003-4975(97)00619-X","article-title":"Improvement in staging of esophageal cancer with the addition of positron emission tomography","volume":"64","author":"Block","year":"1997","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.suc.2020.02.003_bib46","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/cncr.22397","article-title":"Detection of interval distant metastases: clinical utility of integrated CT-PET imaging in patients with esophageal carcinoma after neoadjuvant therapy","volume":"109","author":"Bruzzi","year":"2007","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.suc.2020.02.003_bib47","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1001\/jamasurg.2014.3867","article-title":"Role of repeat 18F-fluorodeoxyglucose positron emission tomography examination in predicting pathologic response following neoadjuvant chemoradiotherapy for esophageal adenocarcinoma","volume":"150","author":"Kukar","year":"2015","journal-title":"JAMA Surg"},{"issue":"6","key":"10.1016\/j.suc.2020.02.003_bib48","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1097\/SLA.0b013e3181bc9c0d","article-title":"[18F]-Fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemoradiation in esophageal cancer","volume":"250","author":"Vallbohmer","year":"2009","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.suc.2020.02.003_bib50","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1053\/j.gastro.2012.05.010","article-title":"The cost effectiveness of radiofrequency ablation for Barrett's esophagus","volume":"143","author":"Hur","year":"2012","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.suc.2020.02.003_bib51","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0003-4975(03)01352-3","article-title":"Barrett's esophagus: the role of laparoscopic fundoplication","volume":"77","author":"Abbas","year":"2004","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.suc.2020.02.003_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1091-255X(03)00136-7","article-title":"Barrett's esophagus","volume":"8","author":"Peters","year":"2004","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"5","key":"10.1016\/j.suc.2020.02.003_bib53","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00000658-200111000-00006","article-title":"Endoscopic surveillance of columnar-lined esophagus: frequency of intestinal metaplasia detection and impact of antireflux surgery","volume":"234","author":"Oberg","year":"2001","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.suc.2020.02.003_bib54","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10388-004-0018-0","article-title":"Guidelines for clinical and pathologic studies on carcinoma of the esophagus, ninth edition: Preface, general principles, part I","volume":"1","author":"Japanese Society for Esophageal Diseases","year":"2004","journal-title":"Esophagus"},{"issue":"11","key":"10.1016\/j.suc.2020.02.003_bib55","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1245\/s10434-008-0065-1","article-title":"Prediction of lymph node status in superficial esophageal carcinoma","volume":"15","author":"Ancona","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.suc.2020.02.003_bib56","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/SLA.0b013e3182369128","article-title":"Prognostic impact of upper, middle, and lower third mucosal or submucosal infiltration in early esophageal cancer","volume":"254","author":"Holscher","year":"2011","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.suc.2020.02.003_bib57","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.amjsurg.2005.07.035","article-title":"Prediction of lymph node status in patients with superficial esophageal carcinoma: analysis of 160 surgically resected cancers","volume":"191","author":"Shimada","year":"2006","journal-title":"Am J Surg"},{"issue":"3","key":"10.1016\/j.suc.2020.02.003_bib58","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/modpathol.3800557","article-title":"Histopathological criteria for additional treatment after endoscopic mucosal resection for esophageal cancer: analysis of 464 surgically resected cases","volume":"19","author":"Eguchi","year":"2006","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.suc.2020.02.003_bib59","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1097\/SLA.0b013e31827017fc","article-title":"The overall prevalence of metastasis in T1 esophageal squamous cell carcinoma: a retrospective analysis of 295 patients","volume":"257","author":"Akutsu","year":"2013","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.suc.2020.02.003_bib60","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/SLA.0b013e31821d4bf6","article-title":"Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett's esophagus at two high-volume centers","volume":"254","author":"Pech","year":"2011","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.suc.2020.02.003_bib61","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1111\/j.1572-0241.2008.01889.x","article-title":"A\u00a0comparison of endoscopic treatment and surgery in early esophageal cancer: an analysis of surveillance epidemiology and end results data","volume":"103","author":"Das","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"2B","key":"10.1016\/j.suc.2020.02.003_bib62","first-page":"1507","article-title":"Results of radiation therapy for superficial esophageal cancer using the standard radiotherapy method recommended by the Japanese Society of Therapeutic Radiology and Oncology (JASTRO) Study Group","volume":"26","author":"Nemoto","year":"2006","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.suc.2020.02.003_bib63","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0360-3016(99)00377-6","article-title":"High dose rate brachytherapy for superficial cancer of the esophagus","volume":"46","author":"Maingon","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.suc.2020.02.003_bib64","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1148\/radiology.196.1.7784580","article-title":"Superficial esophageal cancer: multicenter analysis of results of definitive radiation therapy in Japan","volume":"196","author":"Okawa","year":"1995","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.suc.2020.02.003_bib65","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1067\/mtc.2002.119070","article-title":"Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy","volume":"123","author":"Swisher","year":"2002","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"1","key":"10.1016\/j.suc.2020.02.003_bib66","first-page":"25","article-title":"Cardia cancer: attempt at a therapeutically relevant classification","volume":"58","author":"Siewert","year":"1987","journal-title":"Chirurg"},{"key":"10.1016\/j.suc.2020.02.003_bib67","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ijsu.2018.01.008","article-title":"Neoadjuvant chemotherapy in advanced gastric and esophago-gastric cancer. Meta-analysis of randomized trials","volume":"51","author":"Coccolini","year":"2018","journal-title":"Int J Surg"},{"issue":"22","key":"10.1016\/j.suc.2020.02.003_bib68","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative chemoradiotherapy for esophageal or junctional cancer","volume":"366","author":"van Hagen","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.suc.2020.02.003_bib69","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/COC.0b013e3181aaca26","article-title":"Cisplatin\/Irinotecan versus carboplatin\/paclitaxel as definitive chemoradiotherapy for locoregionally advanced esophageal cancer","volume":"33","author":"Ruppert","year":"2010","journal-title":"Am J Clin Oncol"},{"issue":"34","key":"10.1016\/j.suc.2020.02.003_bib70","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1200\/JCO.2011.36.7490","article-title":"S0356: a phase II clinical and prospective molecular trial with oxaliplatin, fluorouracil, and external-beam radiation therapy before surgery for patients with esophageal adenocarcinoma","volume":"29","author":"Leichman","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.suc.2020.02.003_bib71","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1200\/JCO.2007.12.9593","article-title":"Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781","volume":"26","author":"Tepper","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"15_suppl","key":"10.1016\/j.suc.2020.02.003_bib72","doi-asserted-by":"crossref","first-page":"e15619","DOI":"10.1200\/jco.2009.27.15_suppl.e15619","article-title":"A\u00a0single institution experience with neoadjuvant chemoradiation (CRT) with irinotecan (I) and cisplatin (C) in locally advanced esophageal carcinoma (LAEC)","volume":"27","author":"Sharma","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"24","key":"10.1016\/j.suc.2020.02.003_bib73","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1200\/JCO.2006.06.4840","article-title":"Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response","volume":"24","author":"Ajani","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"19","key":"10.1016\/j.suc.2020.02.003_bib74","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1200\/JCO.2011.36.7136","article-title":"Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection","volume":"30","author":"Smalley","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.suc.2020.02.003_bib75","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa010187","article-title":"Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction","volume":"345","author":"Macdonald","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.suc.2020.02.003_bib76","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1097\/JTO.0b013e3181b26f8e","article-title":"Mature results from a phase II trial of postoperative concurrent chemoradiotherapy for poor prognosis cancer of the esophagus and gastroesophageal junction","volume":"4","author":"Adelstein","year":"2009","journal-title":"J\u00a0Thorac Oncol"},{"issue":"9742","key":"10.1016\/j.suc.2020.02.003_bib77","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial","volume":"376","author":"Bang","year":"2010","journal-title":"Lancet"},{"issue":"9911","key":"10.1016\/j.suc.2020.02.003_bib78","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(13)61719-5","article-title":"Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial","volume":"383","author":"Fuchs","year":"2014","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.suc.2020.02.003_bib79","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/S1470-2045(14)70420-6","article-title":"Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial","volume":"15","author":"Wilke","year":"2014","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.suc.2020.02.003_bib80","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/dote.12126","article-title":"Clinical tools do not predict pathological complete response in patients with esophageal squamous cell cancer treated with definitive chemoradiotherapy","volume":"27","author":"Molena","year":"2014","journal-title":"Dis Esophagus"},{"issue":"6","key":"10.1016\/j.suc.2020.02.003_bib81","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1016\/j.jtcvs.2018.01.086","article-title":"Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinoma","volume":"155","author":"Barbetta","year":"2018","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"1","key":"10.1016\/j.suc.2020.02.003_bib82","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/SLA.0b013e3181b2f6ee","article-title":"Optimum lymphadenectomy for esophageal cancer","volume":"251","author":"Rizk","year":"2010","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.suc.2020.02.003_bib83","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/00000658-199909000-00012","article-title":"Transhiatal esophagectomy: clinical experience and refinements","volume":"230","author":"Orringer","year":"1999","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.suc.2020.02.003_bib84","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.athoracsur.2012.11.045","article-title":"A\u00a0comprehensive review of anastomotic technique in 432 esophagectomies","volume":"95","author":"Price","year":"2013","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"10.1016\/j.suc.2020.02.003_bib85","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1442-2050.2006.00593.x","article-title":"Left thoracoabdominal esophagogastrectomy: still a valid operation for carcinoma of the distal esophagus and esophagogastric junction","volume":"19","author":"Forshaw","year":"2006","journal-title":"Dis Esophagus"},{"issue":"9829","key":"10.1016\/j.suc.2020.02.003_bib86","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/S0140-6736(12)60516-9","article-title":"Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial","volume":"379","author":"Biere","year":"2012","journal-title":"Lancet"}],"container-title":["Surgical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610920300165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610920300165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:10:31Z","timestamp":1758539431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039610920300165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":85,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0039610920300165"],"URL":"https:\/\/doi.org\/10.1016\/j.suc.2020.02.003","relation":{},"ISSN":["0039-6109"],"issn-type":[{"value":"0039-6109","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Esophagus and Gastrointestinal Junction Tumors","name":"articletitle","label":"Article Title"},{"value":"Surgical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suc.2020.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}